9th Annual Biomarkers Congress

Immunology: University of Texas, MD Anderson

Total Score People Score Events Score
50 43 24
Date Event Presentation Speakers
October 28, 2013 Tumor Immunology and Immunotherapy TNFalpha and TLR3/4 induced necrosis pathway Xiaodong Wang
April 6, 2013 AACR Annual Meetings Drug Discovery in Industry, Academia, and Government: What Is the Track Record? Michael A. White
Clinical Trial Design in the Genomic Era Co-Chairpersons: Donald A. Berry, The University of Texas MD Anderson Cancer Center, Houston, TX, and George W. Sledge, Jr., Stanford University School of Medicine, Stanford, CA Donald Berry
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Gordon Mills
Bridging the Gap Between Clinical Research and Laboratory Investigation: Utilizing Presurgical Clinical Trials to Investigate Anti-CTLA-4 Immunotherapy Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX Padmanee Sharma
Whole Body Metabolism and Cancer Chairperson: Philipp E. Scherer, UT Southwestern Medical Center, Dallas, TX Philipp Scherer
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY George A. Calin
Identifying Novel Redox Signaling Pathways for Cancer Chemoprevention: From Fly to the Mouse Garth Powis, The University of Texas MD Anderson Cancer Center, Houston, TX Garth Powis
PAK Family of Kinases in Human Cancer: Past, Present, and Future Rakesh Kumar, George Washington University, Washington, DC Rakesh Kumar
December 2, 2012 Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances Session 5: Advances in the Development of Combinatorial Immune-Based Therapies that Target Checkpoint Pathways Padmanee Sharma
July 10, 2011 Nutritional Immunology: Role in Health and Disease Omega-3 fatty acid regulation of T-lymphocytes Christopher Jolly
Lipid rafts and immune function Robert S. Chapkin
Session 4 | PUFA, lipid rafts and immune function Robert S. Chapkin
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) Th17 Cells Contribute to Intestinal Homeostasis by Inducing Intestinal IgA and pIgR Expression Anthony Cao
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Harnessing the Cell Biology of Dendritic Cells against Cancer (Joint) | Plasmacytoid DC in Cancer Yong-Jun Liu
January 12, 2011 Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction (J1) Adipose Tissue Factors: Modulators of Insulin Sensitivity, Inflammation and Apoptosis | Columbine Ballroom Philipp Scherer
Panel: Mechanisms of Insulin Resistance: Recent Advances and Current Controversies (Joint) | Columbine Ballroom Philipp Scherer
January 12, 2011 Obesity (J2) Adipose Tissue Factors: Modulators of Insulin Sensitivity, Inflammation and Apoptosis | Columbine Ballroom Philipp Scherer
In Search of Targets for Restoring beta-cell Function | Columbine Ballroom Philipp Scherer
November 7, 2010 Frontiers of Immunology in Health and Diseases Frontiers of Immunology in Health and Diseases Chen Dong
October 3, 2010 4th Vaccine and ISV Annual Global Congress Recombinant envelope protein domain III as a dengue vaccine candidate? Alan D.T. Barrett
August 18, 2010 Novel Vaccines: Adjuvants & Delivery Systems Lecithin Nanoparticles as an Adjuvant for Vaccines Zhengrong Cui
August 11, 2009 Inaugural Molecular Diagnostics for Infectious Disease Next Generation Microbial Genomics George Weinstock
Emerging and Re-Emerging Infectious Diseases: Molecular Diagnostic Approaches Juan P. Olano
July 9, 2009 "The 5th RCAI-JSI International Symposium on Immunology 2009 ""Cellular and Genetic View on Autoimmunity" Presentation 5 Michel Gilliet
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Application of New Proteomics Technologies to Drug Discovery : Track 1-3 Yingming Zhao
Title: TBD:Track 2-2 Dihua Yu
Feedstock and Enzyme Improvement for Bioenergy : Track 5-1 Joshua S. Yuan
August 18, 2008 Systems Integration in Biodefense Collection, Focusing, and Metering of DNA in Microchannels Using Addressable Electrode Arrays for Portable Low-Power Bioanalysis Victor M Ugaz
July 20, 2008 WORLD SUMMIT OF ANTIVIRALS Combating Severe Viral Infections Session 2: Etiology and Epidemiology of Viral Infections R. Palmer Beasley
Session 3: Epidemiology and Virology Lu-Yu Hwang
Epidemiology and Prevention of HIV, HBV and HCV Infection among Hard to Reach Drug Users: Experiences from the Inner City Neighborhoods of the United States Lu-Yu Hwang
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
cancer genetics-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
developmental therapeutics-- c-MET Inhibition for Cancer Treatment Razelle Kurzrock
developmental therapeutics-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
developmental therapeutics-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
gastrointestinal (colorectal) cancer-- Advances in Anal Cancer Management (M01) Cathy Eng
gastrointestinal (colorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
gastrointestinal (noncolorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
genitourinary cancer-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies CPO20A) Paul Mathew
genitourinary cancer What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
gynecologic cancer-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
lung cancer-- Therapeutic Modalities for “Small” Stage I Lung Cancers Robert Timmerman
lymphoma and plasma cell disorders-- The Role of Maintenance Therapy in Follicular Lymphoma: Pros and Cons Peter McLaughlin
patient and survivor care-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
patient and survivor care-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
sarcoma/bone and soft tissue cancers-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
tumor biology-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
meet the professor sessions-- Advances in Anal Cancer Management (M01) Cathy Eng
meet the professor sessions-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
meet the professor sessions-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
meet the professor sessions-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
meet the professor sessions-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20A) Paul Mathew
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases RNA Viruses II Alan D.T. Barrett
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases RNA Viruses II Alan D.T. Barrett
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases RNA Viruses II Alan D.T. Barrett
March 2, 2008 MOLECULAR MECHANISMS IN LYMPHATIC FUNCTION & DISEASE The regulation of the real lymphatic function - lymph transport David Zawieja
GENETICS AND TREATMENT OF LYMPHATIC DISORDERS David Zawieja
February 3, 2008 TGF-ß Family in Homeostasis and Disease Signaling System I Andrew P. Hinck
July 28, 2007 Nutritional Immunology: Its Role in Health and Disease Inhibition of autoimmunity and bone loss by n-3 fatty acids Gabriel Fernandes
Mechanisms of omega-3 fatty acid regulation of T-lymphocytes Christopher Jolly
N-3 PUFA, T-Cell inflammation and colon cancer David N McMurray
July 21, 2007 Microbial Pathogenesis: Mechanisms of Infectious Disease Delayed CXC ELR+ chemokine expression during early primary plague pneumonia contributes to disease severity Peter H Dube
Inter-kingdom signaling in bacterial pathogenesis Vanessa Sperandio
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.